These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24815080)

  • 1. Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals.
    de Keyser CE; Koehler EM; Schouten JN; Visser LE; Hofman A; Janssen HL; Stricker BH
    Dig Liver Dis; 2014 Aug; 46(8):720-5. PubMed ID: 24815080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years.
    Ludwig U; Holzner D; Denzer C; Greinert A; Haenle MM; Oeztuerk S; Koenig W; Boehm BO; Mason RA; Kratzer W; Graeter T;
    BMC Endocr Disord; 2015 Aug; 15():41. PubMed ID: 26276551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of statins is associated with lower serum total and non-sex hormone-binding globulin-bound testosterone levels in male participants of the Rotterdam Study.
    de Keyser CE; de Lima FV; de Jong FH; Hofman A; de Rijke YB; Uitterlinden AG; Visser LE; Stricker BH
    Eur J Endocrinol; 2015 Aug; 173(2):155-65. PubMed ID: 26034077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Abdominal Ultrasonography Results of Cappadocia Cohort Study of Turkey Reveals High Prevalence of Fatty Liver.
    Sezgin O; Akpınar H; Özer B; Törüner M; Bal K; Bor S
    Turk J Gastroenterol; 2023 Jun; 34(6):652-664. PubMed ID: 37303246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription of statins in suspected non-alcoholic fatty liver disease and high cardiovascular risk, a population-based study.
    van den Berg EH; Wolters AAB; Dullaart RPF; Moshage H; Zurakowski D; de Meijer VE; Blokzijl H
    Liver Int; 2019 Jul; 39(7):1343-1354. PubMed ID: 30968536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
    Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
    Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use and non-alcoholic steatohepatitis in at risk individuals.
    Dongiovanni P; Petta S; Mannisto V; Mancina RM; Pipitone R; Karja V; Maggioni M; Kakela P; Wiklund O; Mozzi E; Grimaudo S; Kaminska D; Rametta R; Craxi A; Fargion S; Nobili V; Romeo S; Pihlajamaki J; Valenti L
    J Hepatol; 2015 Sep; 63(3):705-12. PubMed ID: 25980762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-alcoholic fatty liver in children and adolescents with excess weight and obesity].
    Guijarro de Armas MG; Monereo Megías S; Navea Aguilera C; Merino Viveros M; Vega Piñero MB
    Med Clin (Barc); 2015 Jan; 144(2):55-8. PubMed ID: 24768200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying non-alcoholic fatty liver disease among asymptomatic overweight and obese individuals by clinical and biochemical characteristics.
    Haentjens P; Massaad D; Reynaert H; Peeters E; Van Meerhaeghe A; Vinken S; Poppe K; Velkeniers B
    Acta Clin Belg; 2009; 64(6):483-93. PubMed ID: 20101871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study.
    Alferink LJ; Kiefte-de Jong JC; Erler NS; Veldt BJ; Schoufour JD; de Knegt RJ; Ikram MA; Metselaar HJ; Janssen H; Franco OH; Darwish Murad S
    Gut; 2019 Jun; 68(6):1088-1098. PubMed ID: 30064987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins and hepatic steatosis: perspectives from the Dallas Heart Study.
    Browning JD
    Hepatology; 2006 Aug; 44(2):466-71. PubMed ID: 16871575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis.
    Petit JM; Pedro L; Guiu B; Duvillard L; Bouillet B; Jooste V; Habchi M; Crevisy E; Fourmont C; Buffier P; Hillon P; Cercueil JP; Verges B
    Diabet Med; 2015 Dec; 32(12):1648-51. PubMed ID: 25981893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Statin Use and Prevalence of Exercise-Related Injuries: A Cross-Sectional Survey of Amateur Runners in the Netherlands.
    Bakker EA; Timmers S; Hopman MTE; Thompson PD; Verbeek ALM; Eijsvogels TMH
    Sports Med; 2017 Sep; 47(9):1885-1892. PubMed ID: 28138920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound Grade of Liver Steatosis Is Independently Associated with the Risk of Metabolic Syndrome.
    Mustapic S; Ziga S; Matic V; Bokun T; Radic B; Lucijanic M; Marusic S; Babic Z; Grgurevic I
    Can J Gastroenterol Hepatol; 2018; 2018():8490242. PubMed ID: 30211140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.
    Du T; Yu X; Yuan G; Zhang J; Sun X
    Cardiovasc Diabetol; 2015 Oct; 14():144. PubMed ID: 26511621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatic steatosis and its relation to liver function tests and lipid profile in patients at medical check-up.
    Briseño-Bass P; Chávez-Pérez R; López-Zendejas M
    Rev Gastroenterol Mex (Engl Ed); 2019; 84(3):290-295. PubMed ID: 30292582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.